Oncology Pharma Inc. (ONPH)

0.0005 0.0000 (0.00%) At close: 01:17PM EDT

Oncology Pharma Inc.

1 Sansome Street
Suite 3500
San Francisco, CA 94104
United States
415-869-1036
https://www.oncology-pharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chuck Wagner	President, Treasurer & Chairman	N/A	N/A	N/A
Mr. George Malesek	Interim Chief Executive Officer	N/A	N/A	N/A
Mr. Dimitri Theofilopolous Esq.	Legal Counsel	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Corporate governance

Oncology Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.